Neuroligin-1 is altered in the hippocampus of Alzheimer’s disease patients and mouse models, and modulates the toxicity of amyloid-beta oligomersJulien Dufort‐Gervais, Jonathan Brouillette|Scientific Reports|2020Cited by 50